Revolutionary Liver Tumour Treatment with Radioembolization
Radioembolization is a revolutionary new treatment for primary and metastatic liver tumours that is revolutionizing the world of oncology. In Radioembolization, Y-91 Santa Fe, tiny glass or plastic microspheres filled with the radioactive isotope Yttrium-90, also known as Y-91 Santa Fe, are injected directly into the tumour. These microspheres are about the size of four red blood cells and look like a bit of dust. This revolutionary treatment is now available in many hospitals and clinics around the world, making it an invaluable tool for those seeking a way to treat their liver tumours.
What is radioembolization?
Radioembolization, Y-91 Santa Fe is a minimally invasive treatment option for liver cancer. Also known as selective internal radiation therapy (SIRT), this treatment involves the injection of tiny microspheres, each about four red blood cells in size, directly into the tumour. These microspheres contain a radioactive isotope, Yttrium-90 (Y-90), which emits radiation to target the tumour and destroy the cancerous cells.
Developed in the 1990s, this innovative treatment has evolved over the years to become more effective and precise. It is now widely used to treat both primary and metastatic liver tumours, with notable success rates. Santa Fe has been one of the leading centres in the use of Radioembolization, Y-91 Santa Fe and has provided treatment for numerous patients from all around the world.
This treatment can provide an alternative for patients who are unable to undergo surgery, chemotherapy, or radiation therapy. It is particularly effective in targeting tumours that cannot be removed surgically or those that have spread to other parts of the liver. Furthermore, radioembolization can help to reduce symptoms and improve the quality of life for patients, while extending their life expectancy.
In summary, radioembolization is a safe and effective treatment for liver cancer that utilizes the power of Y-90 to destroy cancer cells while minimizing harm to healthy tissue. As such, it has become an increasingly popular choice for cancer patients seeking alternatives to traditional treatments.
How does radioembolization work?
Radioembolization, Y-91 Santa Fe works by injecting tiny microspheres containing the radioactive isotope Yttrium-90 directly into the tumour. This treatment is also known as Selective Internal Radiation Therapy (SIRT) or Transarterial Radioembolization (TARE).
The microspheres are inserted through a catheter that is threaded through a small incision in the groin and guided through the blood vessels to the liver. Once the catheter reaches the tumour, the microspheres are released and become lodged in the small blood vessels that supply the tumour with nutrients and oxygen.
The Yttrium-90 emits radiation that destroys the cancer cells. Since the microspheres are so small, the radiation is delivered directly to the tumour, with minimal damage to the surrounding healthy tissue.
This treatment is also effective for treating metastatic liver tumours. In cases where the tumours have spread to multiple sites, radioembolization can be combined with chemotherapy to help shrink the tumours and prolong survival rates.
The development of this treatment was pioneered by doctors at the Radioembolization, Y-91 Santa Fe Program at the University of New Mexico in Santa Fe. It has since been adopted by hospitals and clinics around the world, and has proven to be a promising treatment option for patients with liver cancer.
In the next section, we’ll discuss some of the benefits of radioembolization.
What are the benefits of radioembolization?
Radioembolization, Y-91 Santa Fe, also known as Selective Internal Radiation Therapy (SIRT), has shown to be a highly effective treatment for primary and metastatic liver tumours. Here are some benefits of radioembolization:
1. Targeted treatment: Radioembolization delivers high doses of radiation directly to the tumour site, sparing the healthy liver tissue. This makes it a targeted and precise treatment option.
2. Minimal invasiveness: The treatment is minimally invasive, with the use of small catheters and no need for major surgery. Patients can usually go home the same day or within a few days after the procedure.
3. Effective in advanced cases: Radioembolization has shown to be effective in cases where other treatment options have failed, making it a promising option for patients with advanced liver tumours.
4. Fewer side effects: Radioembolization has fewer side effects compared to other treatments like chemotherapy or radiation therapy. Patients may experience mild nausea, fatigue, or fever, but these usually subside within a few days.
5. Improved quality of life: Studies have shown that patients who undergo radioembolization experience an improvement in their quality of life, including reduced pain and increased survival rates.
Are there any side effects?
As with any medical treatment, there are potential side effects to Radioembolization, Y-91 Santa Fe. However, they are usually minimal and manageable. Some patients may experience fatigue or flu-like symptoms for a few days after the treatment. Others may have some pain or discomfort at the injection site, but this usually resolves within a few days. In rare cases, there may be a risk of radiation exposure to healthcare providers or caregivers, but this can be minimized with proper precautions.
It is also important to note that radioembolization is not recommended for patients with liver tumors that are too large or in too close proximity to critical structures such as the gallbladder or bile ducts. In such cases, alternative treatments such as surgery or ablation may be more appropriate.
In summary, radioembolization with Yttrium-90 is a safe and effective treatment for primary and metastatic liver tumors. It offers many benefits, including minimal side effects and the potential for long-term disease control. With continued advances in technology and research, we can expect to see even better outcomes for patients in the future. If you or a loved one are facing liver cancer, speak with your healthcare provider to determine if radioembolization is an appropriate treatment option.
How long does the treatment take?
The radioembolization treatment typically takes around 1-2 hours to complete. This includes the time needed for preparing the patient, injecting the microspheres into the tumour, and monitoring the patient for any adverse reactions.
One thing to keep in mind is that the treatment may need to be repeated depending on the size and severity of the tumour. Additionally, the patient may need to stay in the hospital for a short period of time for observation.
At Santa Fe Radiology, we use Y-90 microspheres for radioembolization. These microspheres are known for their precision and effectiveness in treating liver tumours. Our team of experts has years of experience in administering this treatment and ensuring the best possible outcomes for our patients.
Overall, radioembolization is a relatively quick and non-invasive procedure that can offer significant benefits to those with liver tumours. If you or a loved one has been diagnosed with liver cancer, it’s important to explore all treatment options and work with a trusted medical professional to determine the best course of action.